Output details

Carbon nanotube length reduction techniques, and characterisation of oxidation state using quasi-elastic light scattering

This paper was based on research collaborating with Nemaura Pharma Ltd, an SME based in Loughborough. Applying engineering analytical and quantifying skills, a feasible way to reduce the size of carbon nanotubes was developed, which enabled the functionalization of the ends of the shortened carbon nanotubes, self-assembly of the nanotubes, and incorporation of anti-cancer drugs for therapeutic applications. This helped the company to overcome a technical bottleneck in carbon nanotube dispersion and size reduction. It led to the granting of a European patent (EU1934138), and further investment from private investors (contact details available).